| |
| |
|
| Insider
Information: |
Gasmi Mehdi |
| Relationship: |
Director |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
274,442 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,102,226 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
274,442 |
|
|
| Total
Value |
$2,102,226 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adverum Biotechnologies, Inc |
ADVM |
Director |
2020-07-20 |
274,442 |
2015-04-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADVM |
Adverum Biotechnologies, ... |
Chief Science & Tech Officer |
• – – |
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
387,031 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2018-06-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
88,496 |
345,258 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2019-02-09 |
4 |
D |
$3.33 |
$41,955 |
D/D |
(12,599) |
332,659 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2019-02-12 |
4 |
D |
$3.55 |
$37,815 |
D/D |
(10,652) |
322,007 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2019-04-21 |
4 |
D |
$5.98 |
$3,522 |
D/D |
(589) |
321,418 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
321,418 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-02-09 |
4 |
D |
$10.24 |
$118,282 |
D/D |
(11,551) |
309,867 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-05-06 |
4 |
OE |
$4.80 |
$120,000 |
D/D |
25,000 |
299,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-06-22 |
4 |
OE |
$4.80 |
$113,304 |
D/D |
23,605 |
298,047 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Chief Science & Tech Officer |
• – – |
2017-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
289,535 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-06-18 |
4 |
OE |
$4.80 |
$53,410 |
D/D |
11,127 |
285,569 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-02-12 |
4/A |
OE |
$4.80 |
$48,000 |
D/D |
10,000 |
284,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-05-05 |
4 |
OE |
$4.80 |
$48,000 |
D/D |
10,000 |
284,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-06-15 |
4 |
OE |
$4.80 |
$48,000 |
D/D |
10,000 |
284,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-05-18 |
4 |
OE |
$4.80 |
$24,000 |
D/D |
5,000 |
279,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-07-20 |
4 |
OE |
$4.80 |
$24,000 |
D/D |
5,000 |
279,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-05-21 |
4 |
OE |
$4.80 |
$17,275 |
D/D |
3,599 |
278,041 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2017-02-12 |
4 |
D |
$3.00 |
$38,379 |
D/D |
(12,793) |
276,742 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2017-04-21 |
4 |
D |
$2.70 |
$1,774 |
D/D |
(657) |
276,085 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-05-20 |
4 |
OE |
$4.80 |
$6,725 |
D/D |
1,401 |
275,843 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-06-17 |
4 |
OE |
$4.80 |
$1,286 |
D/D |
268 |
274,710 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-02-09 |
4/A |
D |
$10.24 |
$158,659 |
D/D |
(15,494) |
274,473 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-02-12 |
4/A |
D |
$11.33 |
$589,876 |
D/D |
(46,976) |
274,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-02-12 |
4/A |
AS |
$15.07 |
$150,690 |
D/D |
(10,000) |
274,442 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2020-05-05 |
4 |
AS |
$16.26 |
$162,573 |
D/D |
(10,000) |
274,442 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
